The business management software developer hiked its overall funding to $465m and its valuation to $2.4bn in a Citi Ventures-backed round.

With a focus on NFTs and the metaverse, Sfermion has raked in capital from limited partners including CMT Digital and Animoca Labs.

The hospitality software developer pushed its overall funding past $250m in a series D round led by SoftBank Vision Fund 2.

Microsoft had been looking for a head of its M12 corporate venturing unit following the departure of its founder, Nagraj Kashyap.

Scott Greenberg, co-founder and CEO of Bento Box Entertainment, a unit of Fox, will serve as CEO of Blockchain Creative Labs.

Hillel Olivestone, Cross River’s head of corporate development, will run unit.

Bristol Myers Squibb was among the participants in cellular therapy developer Clade Therapeutics' series A round, with the proceeds to go to platform development.

Cancer drug developer Parthenon Therapeutics secured the funding in a series A round co-led by Pfizer Ventures and Taiho Ventures.

Cox Enterprises invested in digital media company Axios at a $430m valuation while Bristol Myers Squibb helped enzyme drug developer Nitrase Therapeutics boost its series A round to $45m.

Rohit Giri left a director of corporate development role at BigCommerce to take up a similar position at Splunk, where he will help run its Splunk Ventures unit.